Gene therapy offers hope for kids with fatal batten disease

This study tested a one-time gene therapy for children with a rare, severe brain disease called variant late infantile Batten disease. The treatment delivers a working CLN6 gene into the spinal fluid to help slow the loss of motor and language skills. The trial included 13 children with mild to moderate symptoms and focused on safety and how well the therapy worked.